Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-12-20

FDA Approved: BIMATOPROST — Supplemental Application (Alembic Pharmaceuticals Inc.)

View source ↗

Summary

FDA has approved a supplemental application for BIMATOPROST from Alembic Pharmaceuticals Inc., representing a supplemental approval for the generic ophthalmic p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bimatoprost (bimatoprost)

Snippet

SUPPL AP for BIMATOPROST (BIMATOPROST)